Robert Yau
Oral and Maxillofacial Surgery · Las Vegas, NVNPI 1679971790
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.0%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Axogen at 49.1% of the total. Reporting peaked in 2023 at $3,578 and has fallen 98.6% since, to $51 in 2025.
Across 38 payments — averaging $123.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$2K
- Kls-martin L.p.$1K
- Stryker$633
- Johnson & Johnson$160
- Livanova USA, Inc.$153
- Straumann USA LLC$150
- plus $48 from 2 others
What the payments were for
- Speaking & faculty fees$180%
- Travel & lodging$2,06344%
- Food & beverage$1,67236%
- Gifts$93220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 7 | $2,302 |
| Kls-martin L.p. | 13 | $1,239 |
| Stryker | 4 | $633 |
| Johnson & Johnson | 2 | $160 |
| Livanova USA, Inc. | 2 | $153 |
| Straumann USA LLC | 8 | $150 |
| Baxter Healthcare | 1 | $28 |
| KCI USA, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVANCE NERVE GRAFT$2,192
- AxoGuard Nerve Connector$2,192
- AxoGuard Nerve Protector$2,192
- NA$527
- LEVEL ONE TRAY, W/LID, W/O INSTRUMENT CUTOUTS, FOR INSTRUMENTS$404
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$150
- STRATAFIX$118
- PROLENE$118
- SURGICEL NU-KNIT$118
How this compares
$4,686 in reported general payments places this provider in the 80th percentile of 56 oral and maxillofacial surgery providers in Nevada.
See all oral and maxillofacial surgery providers in Nevada →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pentoxifylline | 18 | $587 |
| Amoxicillin | 150 | $549 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 79 | $471 |
| Ibuprofen | 72 | $198 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $163 |
| Chlorhexidine Gluconate | 36 | $129 |
| Clindamycin Hcl | 18 | $109 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Las Vegas
- Jesse FalkLas Vegas$32K
- Michael MoodyLas Vegas$18K
- Robert SvarneyLas Vegas$4K
- Summer LaneLas Vegas$3K
- Daniel OrrLas Vegas$3K
- Michel DaccacheLas Vegas$2K
- Jeff MoxleyLas Vegas$2K
- Eric SwansonLas Vegas$802
- James SchlesingerLas Vegas$692
- Hung DangLas Vegas$593
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.